MentionFox
Home › funding signals › Arthrosi Therapeutics, Inc.
Form D · on the record

Arthrosi Therapeutics — $60.87M Form D filing, June 2025

Arthrosi Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2025-06-24.

Arthrosi Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on June 24, 2025. The filing reports $60.87M sold. Its industry group is Pharmaceuticals. It names Litain Yeh (Executive Officer, Director, Promoter), Shunqi Yan (Executive Officer, Director, Promoter), John Leaman (Director) (SEC Form D, June 24, 2025).

5 more Pharmaceuticals raises in California within 90 days ↓

Is this your company?

Key facts

Run the free check on Arthrosi Therapeutics, Inc. →

Sell to companies like Arthrosi Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Arthrosi Therapeutics, Inc.

New Form D on file · 2025-06-24 · the record

$60.87M
raise on the record
D
filing
13
investors in
CALIFORNIA
based
Open the record →

What the record says

FilingForm D
Filed2025-06-24
Industry groupPharmaceuticals
Entity typeCorporation
Incorporated inDELAWARE
BasedLAGUNA HILLS, CALIFORNIA
CIK1741062
Accession0001741062-25-000002

Pitching, partnering or investing alongside them? See who really runs and owns Arthrosi Therapeutics, Inc.

Free to see. No signup.

Keep reading

More on the people and the money behind Arthrosi Therapeutics, Inc., from the filings we hold.

More raises like this

Pharmaceuticals raises by companies based in California, filed within 90 days of this one, largest first.

What do you want to do with Arthrosi Therapeutics, Inc.?

Get the full cited report on Arthrosi Therapeutics, Inc.

What the filing shows about Arthrosi Therapeutics, Inc.

  • 13 investors had already put money in when it filed.
  • The filing names 9 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Arthrosi Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Who the filing names, and in what role

The filing gives Arthrosi Therapeutics, Inc.'s address as 23052 Alcalde Drive, Suite A, Laguna Hills, CA 92653.

What the filing says

  • Offered: $153,110,000. Sold: $60,869,972. Left to sell: $92,240,028. (filing)
  • Investors: 13 had already invested. (filing)
  • Date of first sale: June 6, 2025. (filing)
  • Types of securities: Equity. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Arthrosi Therapeutics, Inc. See pricing

Is Arthrosi Therapeutics, Inc. a real, registered company?

Arthrosi Therapeutics, Inc. is a registered filer with the SEC (CIK 1741062) and has filed since 2023-03-03. 3 filings are on record, the latest on 2025-06-24.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Arthrosi Therapeutics, Inc.?

Arthrosi Therapeutics, Inc.'s Form D of 2025-06-24 names Litain Yeh, Shunqi Yan, John Leaman and 6 more as its officers, directors or promoters.

How much has Arthrosi Therapeutics, Inc. raised?

Its new offerings report $82.87M sold across 3 offerings, as its own filings state.

Filing history · 3 filings on this registrant
Form D · 2023-03-03 · $15MForm D · 2024-01-26 · $7MForm D · 2025-06-24 · $60.87M · this page 2023-03-03 2025-06-24

Each marker is one filing. The larger marker is the filing this page is about.

Pharmaceuticals · by week

Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.

Want the whole picture on Arthrosi Therapeutics, Inc.?

What the filing shows about Arthrosi Therapeutics, Inc.

  • 13 investors had already put money in when it filed.
  • The filing names 9 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Arthrosi Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Arthrosi Therapeutics, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Arthrosi Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

RSS

Tools for this story

Each opens in a new tab, filled in for Arthrosi Therapeutics, Inc.. With no account yet, you sign up free and land on the result.

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Arthrosi Therapeutics, Inc.: Raised $60.87M, Form D filed 2025-06-24
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/arthrosi-therapeutics-inc-form-d-25000001
Last updated 2026-11-01
Primary record: SEC filing 1 · SEC filing 2
Arthrosi Therapeutics raised $60.87M — SEC Form D filing, June 2025. MentionFox, 2026-11-01. https://mentionfox.com/funding/arthrosi-therapeutics-inc-form-d-25000001